Post-Cataract Corneal Decompensation in Fuchs Endothelial Dystrophy
A 74-year-old woman with known Fuchs endothelial dystrophy (guttae on specular microscopy, baseline central endothelial cell count 1,150 cells/mm² and 3+ confluent central guttae) underwent uncomplicated phacoemulsification with in-the-bag IOL implantation in the right eye 5 weeks ago. Surgery used standard phaco power with a dispersive viscoelastic. At the 1-week visit the cornea was mildly edematous and cleared on topical steroids and hypertonic saline. At 5 weeks she reports painless, progressive blurring worse in the mornings. Visual acuity is 20/100 OD, improving to 20/60 after 2 hours of eye opening. Central corneal thickness is 690 µm (preop 590 µm), and there is 2+ stromal edema with microcystic epithelial edema but no epithelial defect. IOP is 15 mmHg. The anterior chamber is quiet and the IOL is well positioned.
1. Distinguish the likely mechanism of her current edema from pseudophakic bullous keratopathy and from elevated IOP, and explain why the morning-worse pattern and the improvement with eye opening are diagnostically useful.
Read the worked answer
The key discriminator is the diurnal pattern tied to overnight eyelid closure. With a compromised endothelial pump (Fuchs), overnight lid closure lowers corneal temperature and reduces evaporative drying, so stromal hydration increases and edema peaks on waking; opening the eye restores evaporation and cooling, and edema partially clears. This pattern is characteristic of endothelial failure, not of IOP-driven edema (which would not improve reliably with eye opening alone and would track IOP) and not of epithelial disease.
- Pseudophakic bullous keratopathy is a descriptive endpoint of endothelial cell loss after surgery; here the pre-existing low count and confluent guttae make Fuchs the dominant driver, and the absence of epithelial bullae means she has not yet reached that stage.
- IOP-related edema is excluded by a normal IOP of 15 mmHg and a quiet chamber.
- The thickening from 590 to 690 µm with 2+ stromal edema confirms a hydration problem, and the absence of epithelial defect argues against infectious or neurotrophic causes.
So the working diagnosis is decompensating Fuchs dystrophy after cataract surgery, and the trajectory (worsening rather than resolving between weeks 1 and 5) signals that medical therapy alone is unlikely to be durable.
2. Outline the next 3-6 months of management, including what medical measures you would use, what you would tell her about prognosis, and the threshold at which you would escalate to surgery.
Read the worked answer
Medical optimization first, but time-boxed.
- Hypertonic saline 5% drops four times daily and 5% sodium chloride ointment at bedtime to draw fluid out overnight, when edema is worst.
- Topical steroid at the lowest frequency that controls inflammation (e.g., loteprednol or prednisolone acetate 1% tapered), recognizing that steroids do not restore endothelial cells and prolonged use risks IOP rise and infection.
- Avoid unnecessary topical toxicity and confirm no IOP elevation on steroids.
Counseling. Endothelial cells do not regenerate; the count will continue to decline. Improvement is likely to be partial and fluctuating, and she should expect that surgery (endothelial keratoplasty) is probable rather than optional. Set expectations that vision may remain limited until the cornea is replaced.
Escalation threshold. Refer for Descemet membrane endothelial keratoplasty (DMEK) - preferred over penetrating keratoplasty given a healthy stroma and no scarring - if:
- Best-corrected vision remains worse than ~20/40-20/60 with persistent symptoms after 3 months of maximal medical therapy, or
- Edema progresses to epithelial bullae, recurrent erosions, or pain, or
- Central thickness continues to climb despite treatment.
If cataract surgery were still pending in the fellow eye, the lesson is to consider combined phaco-DMEK or staged endothelial keratoplasty rather than standalone phaco in a cornea this compromised.